We’re building on a legacy of innovation and commitment to revolutionizing health science. Working together, we’ve already impacted health worldwide in many ways, including:
700
700 peer-reviewed publications describing our TB test as demonstrating excellent performance in a wide variety of settings
75
Providing workflows that enabled the testing of more than 75 million individuals for COVID-19
1500
Introducing over 1,500 new antibodies, kits, and reagents annually for life science research
2
Supplying more than two million scientists across pharma, biotech, and academia with Revvity’s software solutions
40
Screening 40 million babies annually for life-threatening diseases across 110 countries
